Anti–TNF-a agents have been widely used in Crohn’s disease and other autoimmune-mediated inflammatory diseases, such as rheumatoid and psoriatic arthritis, psoriasis, and ankylosing spondylitis [36]. The gene discussed is TNF; the disease is psoriatic arthritis.